| Carnes Chiropractic And Wellness Center | |
|
2323 W Main St Ste 109 Dothan AL 36301-1287 | |
| (334) 794-2225 | |
| Not Available |
| Full Name | Carnes Chiropractic And Wellness Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 2323 W Main St Ste 109, Dothan, Alabama |
| Authorized Official Name and Position | Robert M Carnes (CEO) |
| Authorized Official Contact | 3347942225 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Carnes Chiropractic And Wellness Center 2323 W Main St Ste 109 Dothan AL 36301-1287 Ph: (334) 794-2225 | Carnes Chiropractic And Wellness Center 2323 W Main St Ste 109 Dothan AL 36301-1287 Ph: (334) 794-2225 |
| NPI Number | 1053554675 |
|---|---|
| Provider Enumeration Date | 04/13/2009 |
| Last Update Date | 06/25/2012 |
| Medicare PECOS PAC ID | 0547417388 |
|---|---|
| Medicare Enrollment ID | O20120829000486 |
News Archive
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.
Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053554675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 1003 (Alabama) | Primary |
| Provider Name | Robert M Carnes |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1568527497 PECOS PAC ID: 9335140730 Enrollment ID: I20070129000132 |
News Archive
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.
Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
| Provider Name | Mary Ashley Carnes |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1699126854 PECOS PAC ID: 4183916323 Enrollment ID: I20160708001984 |
News Archive
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.
Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
| Provider Name | Jessica G Monteleone |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1487850608 PECOS PAC ID: 1557378973 Enrollment ID: I20220824002645 |
News Archive
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.
Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
News Archive
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Australia's Environment Protection Authority (EPA) has announced fears of groundwater contamination beneath up to 2000 homes. The EPA said that industrial activity at the former Hills Industries site in Edwardstown, south of Adelaide, caused dangerous materials - including a chemical known to cause cancer - to seep into the groundwater.
McDermott Will & Emery is pleased to announce the Firm's Health Industry Advisory Practice Group was honored as the "Health Team of the Year" during the Chambers USA Awards in New York on June 10, 2010. This is the first time an award in this category has been given on a national basis by Chambers, and McDermott was selected over four other finalist firms.
Eleven randomly selected FDA advisory committees recommended approval for 79% of prescription drugs and medical devices that they considered during a seven-year period, according to a study released on Monday by the National Research Center for Women & Families, Bloomberg/Houston Chronicle reports.
...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.
› Verified 7 days ago
Wiregrass Wound Care Consultants Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1908 Fairview Ave, Dothan, AL 36301 Phone: 251-295-2815 Fax: 251-295-2815 | |
Dothan Family Practice Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1891 Honeysuckle Rd Ste 2a, Dothan, AL 36305 Phone: 334-794-6504 Fax: 334-793-4452 | |
Primecare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4126 West Main Street, Dothan, AL 36305 Phone: 334-793-2120 Fax: 334-671-2930 | |
Samc-houston Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1806 Fairview Ave, Dothan, AL 36301 Phone: 334-677-5986 Fax: 334-677-4901 | |
Southern Clinic Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1901 Melba Dr, Dothan, AL 36301 Phone: 334-794-6611 Fax: 334-794-6614 | |
Sha Diabetes Center Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 172 Luds Way, Dothan, AL 36304 Phone: 334-475-0646 Fax: 334-888-8445 |